Skip to main content

MediNews- june-2013/

1. The MOH has suspended the manufacture and sale of all three drugs-  anti-diabetes drug pioglitazone, painkiller analgin and anti-depressant deanxit under Section 26A of the Drugs and Cosmetics Act, 1940 with immediate effect, through a notification issued on June 18. Under the Drugs and Cosmetic Rule 30-B, the import and marketing of any drug the use of which is prohibited in the country of origin, is banned in India. one month back, MOH had suspended sale of dextropropoxyphene, sold as Wockhardt's Proxyvon, a widely-used pain-killer.
2.Rs 500 crore sanctioned for establishing research units in 80 government medical colleges in 12th.plan.To encourage and strengthen an environment of research in government medical colleges and bridge the gap in infrastructure, which is inhibiting health research in medical colleges,The government therefore felt an urgent need to provide assistance to medical colleges to set up appropriate research facilities to promote and encourage quality medical research and evidence-based application of diagnostic procedures, processes and methods in the country.
3.Cabinet clears laboratory network for epidemics, calamities -to set up 10 regional laboratories, 30 state-level laboratories and 120 medical college-level labs for establishing a network to manage epidemics and natural calamities.

Comments